Calcium antagonists and deep gingival pockets in the population-based SHIP study

Area of Science:

• Periodontology
• Pharmacology
• Epidemiology

Background:

• Gingival overgrowth is a known side effect of calcium channel blockers (CCBs).
• Previous studies suggest CCB-induced gingival hyperplasia may worsen periodontal disease.
• Limited epidemiological data exist on the association between CCB use and periodontitis.

Purpose of the Study:

• To investigate the association between calcium antagonist intake and periodontitis.
• To analyze this relationship considering major periodontitis risk factors.
• To assess the impact of CCBs on periodontal parameters in a large population.

Main Methods:

• Cross-sectional epidemiological study of 4290 subjects (aged 20-80).
• Assessment of periodontal parameters (attachment loss, probing depth, tooth count) and risk factors.
• Matched-pair analysis comparing CCB users (n=456) with non-users (n=456).

Main Results:

• CCB users exhibited significantly deeper gingival pockets compared to non-users (P < 0.001).
• Logistic regression confirmed deeper probing depths, adjusted for risk factors.
• No significant differences in clinical attachment loss or tooth count were observed between groups.
• Gingival overgrowth risk was higher in smokers using CCBs.

Conclusions:

• Calcium antagonist treatment is associated with gingival overgrowth but not an aggravation of periodontal disease in the general population.
• Smoking interacts with CCB use, highlighting the multifactorial nature of gingival overgrowth.
• The findings emphasize the importance of considering smoking status in patients experiencing CCB-related gingival side effects.